Prostate Cancer - Results from #520

The Effect of Vasectomy Reversal on Prostate Cancer Risk: International Meta-Analysis of 684,660 Men with Vasectomies - Beyond the Abstract April 6, 2018

Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer - Beyond the Abstract February 23, 2018

Investigation of the Beam Penumbra Effect on Prostate IMRT Dose Conformity and Uniformity – Beyond the Abstract February 14, 2018

Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists: Beyond the Abstract January 1, 2018

Treatment decision incongruence associated with lower health-related quality of life in prostate cancer survivors. Results from the PiCTure study: Beyond the Abstract December 20, 2017

Ruling Out Clinically Significant Prostate Cancer with Negative Multi-Parametric MRI: Beyond the Abstract December 20, 2017

Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: Beyond the Abstract December 12, 2017

Absorbable Hydrogel Spacer Use in Prostate Radiotherapy: Review of Phase 3 Clinical Trial Published Data: Beyond the Abstract December 6, 2017

The Value of PSA Density in Combination with PI-RADS for the Accuracy of Prostate Cancer Prediction - Beyond the Abstract November 27, 2017

Cancer deaths due to lack of universal access to radiotherapy in the Brazilian public health system: Beyond the Abstract November 14, 2017

Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy: Beyond the Abstract October 24, 2017

Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: Beyond the Abstract October 16, 2017

Characterization of Differences Between Prostate Cancer Patients Presenting with De Novo Versus Primary Progressive Metastatic Disease: Beyond the Abstract October 9, 2017

Nadir PSA is a Strong Predictor of Treatment Outcome in Intermediate and High Risk Localized Prostate Cancer Patients Treated by Definitive External Beam Radiotherapy and Androgen Deprivation: Beyond the Abstract September 25, 2017

Focal Therapy Eligibility Determined by MRI/US Fusion Biopsy: Beyond the Abstract September 25, 2017

Communication Matters: Exploring the Intersection of Family and Practitioner End of Life Communication: Beyond the Abstract September 22, 2017

Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital: Beyond the Abstract September 8, 2017

Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TOAD): a randomised, multicentre, non-blinded, phase 3 trial: Beyond the Abstract August 25, 2017

Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy: Beyond the Abstract August 15, 2017

Analyzing the Learning Curve for MRI-transrectal Ultrasonography Fusion-guided Transrectal Prostate Biopsy: Beyond the Abstract August 15, 2017

Page 27 of 58